TMK POSTS SOLID RESULTS FOR Q2FYE2025
TMK Chemical Bhd (“TMK”) reported Q2FYE2025 revenue of RM263.7 million, a 2.2% quarter-on-quarter increase, supported by higher sales volume with chemical management services remaining the main contributor. PAT rose 2.6% Q-o-Q to RM21.3 million. For 1HFYE2025, TMK posted revenue of RM521.7 million and PAT of RM42.0 million.
TALIWORKS ANNOUNCES Q2FYE2025 RESULTS
Taliworks Corporation Berhad reported Q2 2025 revenue of RM113.3 million, up 14.4% year-on-year, with PAT of RM17.1 million, supported by construction, toll highway and renewable energy segments. The Board declared a second interim dividend of 0.5 sen per share, equivalent to a 6.4% yield.
FARM FRESH DELIVERS STELLAR QUARTERLY PERFORMANCE, PROPELLED BY 26.2% SURGE IN PATAMI
Farm Fresh Berhad (“Farm Fresh”) delivered a strong start to FY2026 with Q1 revenue rising 7.8% year-on-year to RM260.6 million and PATAMI up 26.2% to RM32.8 million, driven by strong demand for new product launches, lower raw material costs, and contributions from regional expansion.
OPTIMAX DELIVERS 11.9% PATAMI GROWTH IN 1HFYE2025
Optimax Holdings Berhad (“Optimax”) posted a 6.5% year-on-year revenue growth to RM34.1 million in Q2FYE2025, driven by new clinics and strong contributions from East Malaysia and Cambodia. Profit after tax and minority interests rose 10.4% to RM4.2 million. CEO Sandy Tan said the Group will focus on maximising utilisation at new centres and expanding its medical tourism segment.
CREST BUILDER’S Q2FYE2025 NET PROFIT QUANTUM LEAPS BY ALMOST FOUR-FOLD
Crest Builder Holdings Berhad (“CBHB”) posted strong results for Q2FYE2025 with PBT up 88.6% to RM3.3 million and PAT nearly quadrupling to RM2.6 million, driven by a 12.5% revenue growth to RM141.1 million.
For 1HFYE2025, revenue rose 9.5% to RM255.4 million, while PAT more than tripled to RM4.9 million. The Group’s performance was supported by solid progress billings, a robust RM1.6 billion order book, and RM300 million in unbilled sales, providing clear earnings visibility.
T7 GLOBAL POSTS 12.5% NET PROFIT GROWTH IN 1HFYE2025
T7 Global Berhad reported a 15.5% Y-o-Y revenue growth to RM173.3 million in Q2FYE2025, with PAT at RM8.7 million. For 1HFYE2025, revenue rose to RM312.1 million, led by strong contributions from the Energy segment.
PHARMANIAGA MAINTAINS UPWARD MOMENTUM IN Q2 FY2025, REINFORCING TURNAROUND STRATEGY
Pharmaniaga Berhad (“Pharmaniaga”) recorded a PAT of RM4.2 million for Q2 FY2025, up 9.5% year-on-year, on the back of RM926.9 million in revenue, a 10.6% increase. EBITDA rose 9.2% to RM34.2 million, with the Manufacturing Division remaining the main driver of profitability, contributing over 80% of net profit. The Group’s steady financial recovery supports its path towards exiting PN17 status by early 2026.
NORTHEAST ACHIEVES 121.7% INCREASE IN PROFIT AFTER TAX
Northeast Group Berhad (“Northeast”) reported a 46.9% year-on-year revenue increase to RM31.7 million for Q3FY2025, with PAT more than doubling to RM7.1 million. For the 9-month period, revenue rose 21.4% to RM83.3 million, supported by sustained demand from semiconductor and photonics industries across Malaysia, Europe, and North America.
E&O STARTS FY2026 WITH 22% PAT GROWTH IN Q1
Eastern & Oriental Berhad posted Q1FY2026 revenue of RM183.5 million and PAT of RM50.1 million, driven by stronger property sales and hospitality growth.
CARLO RINO ANNOUNCES FULL YEAR FINANCIAL RESULTS, WITH E-COMMERCE DISTRIBUTION CHANNEL’S 33% REVENUE GROWTH
Carlo Rino Group Berhad posted revenue of RM98.9 million and PAT of RM15.7 million for FYE2025, driven by a 33.6% surge in e-commerce sales. The Group closed the year with a strong net cash position of RM91.9 million, reinforcing its capacity for future growth.
